M.G.J. V. D.
- Country
- The Netherlands
- Department
- interne oncologie
Research Overview
- Evaluation of MEDI5752 in Patients with Advanced Solid Tumors: A Clinical Trial
- Evaluation of MK-1484 Monotherapy and Combination with Pembrolizumab in Adults with Advanced or Metastatic Solid Tumors
- A Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects with Advanced Solid Tumors (KEYNOTE-158)
Data & Insights
Has run more than one trial at 14 of 63 partner sites.
Specializations
Solid Tumor Expertise
The investigator specializes in treating advanced solid tumors, with particular emphasis on metastatic malignancies. Their research encompasses various tumor types, including breast cancer, biliary tract cancer, and endometrial cancer.
- Advanced Solid Tumors
- Metastatic Cancer Treatment
- Gynecological Cancers
Their work extends to investigating novel therapeutic approaches for patients with unresectable tumors.
Molecular Oncology
The investigator focuses on targeted therapy approaches, particularly in tumors with specific genetic alterations such as KRAS G12C mutations and HER2-expressing cancers.
- Molecular Targeted Therapies
- Genetic Mutation Analysis
- Biomarker Research
Their research includes evaluation of tumor molecular profiles for personalized treatment strategies.
Therapeutic Innovation
The investigator conducts research in novel therapeutic combinations, including investigation of monotherapy and combination approaches for various cancer types.
- First-in-Human Studies
- Combination Therapy Development
- Treatment Response Assessment
Their work includes evaluation of immunotherapy responses and development of new treatment protocols.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.